Literature DB >> 15908276

Chronic red blood cell exchange to prevent clinical complications in sickle cell disease.

Sergio Cabibbo1, Carmelo Fidone, Giovanni Garozzo, Agostino Antolino, Giovanna Oriella Manenti, Francesco Bennardello, Vincenzo Licitra, Salvatore Calabrese, Francesco Costantino, Simone Travali, Roberto Distefano, Pietro Bonomo.   

Abstract

We tracked the results of 394 manual or automatic red blood cell exchanges done with a cell separator in 20 sickle cell patients at high risk for recurrent complications. Over an average of 6 years, none of the patients developed complications related to the procedure or to the increased blood use. It was safe and effective in preventing complications of sickle cell disease, and if done automatically, reduced iron overload. Ferritin levels also decreased in patients treated with automatic red blood cell exchange. Furthermore, using Single Donor Red Blood Cell units (SDRC) we reduced the potential exposure to transfusion transmitted infectious diseases (TTI).

Entities:  

Mesh:

Year:  2005        PMID: 15908276     DOI: 10.1016/j.transci.2005.03.003

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  5 in total

1.  Correspondence (letter to the editor): prevention is more cost effective.

Authors:  Jürgen Otto
Journal:  Dtsch Arztebl Int       Date:  2009-11-13       Impact factor: 5.594

2.  Erythroexchange in sickle cell disease. A three-step procedure to remove more haemoglobin S.

Authors:  Maurizio Govoni
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

3.  Comparative efficacy in red blood cell exchange transfusions with different apheresis machines in patients with sickle cell disease.

Authors:  Nurhilal Buyukkurt; Ilknur Kozanoğlu; Asli Pan Korur; Suheyl Asma; Mahmut Yeral; Soner Solmaz; Fatih Kandemir; Cigdem Gereklioglu; Cagla Sariturk; Can Boga; Hakan Ozdogu
Journal:  Indian J Hematol Blood Transfus       Date:  2017-11-07       Impact factor: 0.900

4.  American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support.

Authors:  Stella T Chou; Mouaz Alsawas; Ross M Fasano; Joshua J Field; Jeanne E Hendrickson; Jo Howard; Michelle Kameka; Janet L Kwiatkowski; France Pirenne; Patricia A Shi; Sean R Stowell; Swee Lay Thein; Connie M Westhoff; Trisha E Wong; Elie A Akl
Journal:  Blood Adv       Date:  2020-01-28

Review 5.  Spectra Optia® for Automated Red Blood Cell Exchange in Patients with Sickle Cell Disease: A NICE Medical Technology Guidance.

Authors:  Iain Willits; Helen Cole; Roseanne Jones; Kimberley Carter; Mick Arber; Michelle Jenks; Joyce Craig; Andrew Sims
Journal:  Appl Health Econ Health Policy       Date:  2017-08       Impact factor: 2.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.